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1 INTRODUCTION 
1.1 Periodontitis 
1.1.1 Periodontal apparatus 
The healthy periodontal apparatus is composed of two hard and two soft tissues: the 
cementum and the alveolar bone as well as the gingiva and the periodontal ligament 
(Bartold et al. 2006). Figure 1 shows the components of the periodontal apparatus. It 
represents the supporting apparatus of teeth in function and occlusal relationships 
(Palumbo et al. 2011). 
 
 
Figure 1: Components of the periodontal apparatus. left: illustration of a tooth and its surrounding 
tissues, right: histological picture of periodontal apparatus (Catón 2011). 
 
The first soft tissue is the gingiva, which surrounds the tooth and overlays the jaw 
bone, whilst being tightly bound to the underlying bone. This presents an effective 
barrier against invasive pathogens as long as the periodontium is healthy. A healthy 
gingiva shows no reaction, such as bleeding, to periodontal probing or tooth 
brushing and has a coral pink color (Rateitschak 1989). The second soft tissue is a 
specialized connective tissue that represents the connection between cementum 
and alveolar bone of the tooth. Its complex fiber network is an elastic structure and 
is firmly anchored by Sharpey´s fibers (Beertsen et al. 1997). The periodontal 
ligament attaches the tooth to the alveolar bone socket and is also important for 
propriception. It is mainly composed of collagen fibers, is highly vascularized and 
contains many cells, including fibroblasts, cementoblasts or osteoblasts (Lekic et al. 
1996).  The cementum, a hard tissue and the substance that covers the root of a 
tooth, is a specialized calcified substance. It is an avascular mesenchymal tissue 
that attaches the teeth to the alveolar bone by anchoring the periodontal ligament 
and has the highest fluoride content of all mineralized tissues. The tissue is formed 
continuously throughout lifetime to guarantee an intact attachment (Rateitschak 
1989). There are different types of cementum, including cellular and acellular. 
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Findings from previous studies showed that the cementum formed after periodontal 
treatments is mostly cellular (Sculean et al. 2005). The fourth component of the 
periodontium is the alveolar bone, which surrounds the tooth. It is also known as 
dental alveoli or alveolar process. The alveolar bone is attached to the cementum 
and also to the root of the tooth by the periodontal ligament. It is also modified 
throughout life, animated by various external factors (Rateitschak 1989). 
 
1.1.2 Pathogenesis 
One of the most common causes for tooth loss in adults is periodontitis, which is 
defined as a bacteria-induced inflammatory disease of the periodontal tissues (Park 
2011). The disease progresses distinctly and is marked by clinical attachment loss, 
alveolar bone resorption, periodontal pocketing and gingival inflammation (Pihlstrom 
et al. 2005). The destruction of the periodontal apparatus is caused by the 
inflammation of the host as reaction to the microbial challenge (Darveau et al. 2010). 
The host response is modulated through a multitude of factors, such as genetics, 
general health, smoking habit, diet or other social determinants (Bartold et al. 2013). 
The latest epidemiological data in the USA has shown a very high prevalence of 
periodontitis of over 47% of adults (Eke et al. 2012). The fifth German oral health 
study (DMS V) from 2014 showed that there is still the need for periodontal 
treatments, although young adults show less periodontal diseases, due to an 
impending demographic change in Germany. In 2030, the majority of the population 
will be senior citizens and therefore the regeneration of lost periodontal tissues will 
still be a challenge in the German health system (Jordan et al. 2014). Periodontitis is 
not only a risk for early tooth loss, it can also lead to other systemic diseases like 
atherosclerosis, diabetes mellitus, rheumatoid arthritis and adverse pregnancy 
outcomes (Kebschull et al. 2010), (Madianos et al. 2013). Bacteria associated with 
periodontitis are a group of Gram-negative predominantly anaerobic species, the 
more prominent being the “red complex”, which are Porphyromonas gingivalis (P. 
gingivalis), Treponema denticola (T. denticola) and Tannerella forsythia (T. 
forsythia) (Holt 2005). Another bacterium responsible for periodontitis is 
Aggregatibacter actinomycetemcomitans, mainly associated with aggressive 
periodontitis (Schacher et al. 2007). Substances released from bacterial biofilm, 
consisting of the populations of above-named bacteria, are e.g. endotoxins, 
lipopolysaccharides (LPS), antigens or other virulence factors. They gain access to 
the gingival tissue and initiate an inflammatory immune response. This response is 
composed of a cellular activation of the host defence cells, which are inflammatory 
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mediators including cytokines, arachidonic acid metabolites and proteolotic 
enzymes. The activation of these cells leads to tissue destruction and bone 
resorption (figure 2) (Yucel-Lindberg and Båge 2013). 
 
 
Figure 2: Pathogenesis. Bacterial products lead to activation of the host cells, via several 
intermediate steps to the activation of osteoclasts and MMPs which ends in the clinical picture of 
periodontitis (Golub et al. 1998). 
 
The immunoinflammatory response is described as a “double-edged sword”, 
because on the one hand it causes destruction and on the other it provides specific 
antibodies and polymorphnuclear neutrophils (PMNs), which represents the 
dominant natural factors responsible for control of the bacterial challenge (Kornman 
1999).  
Once periodontitis is established, the collagen tissues are lost and the periodontal 
ligament is reduced in height and volume. These tissues are replaced by the 
downgrowth of gingival epithelium. By then, there is a defect marked clinically by 
bone and periodontal ligament loss, gingival pockets and recession of the gingival 
margin (figure 3) (Amar 1996). 
In a US study from 2012 (with data from the 2009 and 2010 National Health and 
Nutrition Examination Survey (NHANES) cycle) over 47% of the adults aged 30 
years and older, representing 64.7 million adults, suffer from periodontitis (Eke et al. 
2012). This huge number clarifies the importance of researching and developing 
new and effective treatment options for periodontitis. A common and reliable 
procedure for regenerating the lost periodontal tissues has to be established. The 
conventional treatment of periodontitis is described in the following section.  
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Figure 3: Clinical signs of periodontitis. Inflammation of the supporting structures of the tooth, 
progressive destruction of the periodontal ligament and loss of the alveolar bone (http://www.dent-
wiki.com/foundations_of_periodontics/characteristics-of-chronic-periodontitis). 
 
1.1.3 Treatment of periodontitis 
One of the most difficult challenges in periodontics is the regeneration of the tooth 
supporting structures, which reduce as a result of periodontal disease progression 
(Lee et al. 2005). A periodontal therapy may cause either a repair or a regeneration 
of the surrounding tissues. Repair means healing of the tissues without maintaining 
its original morphology and function, like a non-functional scarring, whereas 
regeneration is defined as a complete recovery of the periodontal tissues in both 
structure and function. Therefore, regeneration is equivalent to the formation of 
alveolar bone and the building of collagen fibers that insert in newly formed 
cementum along the root (Illueca et al. 2006) A complete new periodontal apparatus 
is the entirety of bone, cementum and periodontal ligament (Sharpey´s fibers) 
(LeBlanc and Reisz 2013). The natural healing of wounds normally results in 
scarring or repair, therefore it is necessary to manipulate the natural healing 
process.  
Conventional therapies for periodontitis are scaling and root planning as well as 
various surgical procedures. Their goal is to eliminate inflamed tissues and bacterial 
contamination with the result of these treatment options is more a repair than 
regeneration. There is a limitation for conventional treatments. On these grounds 
research focuses on root surface alteration, progenitor cell manipulation, cell 
exclusion, wound stabilization and growth factor enrichment (Amar 1996). The most 
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approved techniques so far are guided tissue regeneration (GTR) (Siciliano et al. 
2011) and osseous grafting (Chen et al. 2013).  
Frequently, the loss of teeth is caused by the progressive bone resorption (Duan et 
al. 2011). Current periodontal surgical treatment options, like scaling and rootplaning 
or open - flap debridement, have been established to eliminate inflammation and 
thus a disease progression, but are limited in periodontal regeneration (Crea et al. 
2014). The regeneration of the lost alveolar bone is promoted by autografts (bone 
marrow), allografts (demineralized freeze-dried bone) and alloplastic (ceramics, 
hydroxyapatite, polymers and bioglass) materials, but the regeneration of alveolar 
bone is not the major challenge (Reynolds et al. 2003). Further researches should 
be focused on the regeneration of the periodontal ligament and newly formed 
cementum (Bartold 2006).  
The goal is a complete regeneration, which can only be achieved with a network of 
stem cells, growth factors and environmental conditions (Lee et al. 2005). 
Periodontal treatments are limited by the formation of a long junctional epithelium 
and an insufficient formation of new cementum (Mardinger et al. 2012) (Dan et al. 
2014). The tooth only disposes of a stable periodontal apparatus if the connection 
between root surface and alveolar bone is composed of newly generated 
periodontal ligament fibers inserting into new cementum (Duan et al. 2011). 
The complex process of periodontal regeneration depends on locally derived 
progenitor cells, which are able to differentiate into periodontal ligament-forming 
cells, mineral-forming cementoblasts and bone-forming osteboblasts (Bartold and 
Narayanan 1998). One of the most difficult parts in regenerating the periodontal 
apparatus is the cementogenesis. The precise mechanism of cementum formation is 
still unclear. The theory is that a special matrix is generated on the newly formed 
dentin surface, although the precise function of this matrix is still unclear (Lindskog 
1982; Hirooka 1998).  
The most reliable cells for regenerating cementum, alveolar bone and PDL 
(periodontal ligament) are cementoblasts, osteoblasts and fibroblasts (Catón et al. 
2011). The precursors of these cells are mesenchymal stem cells. Stem cells have 
the potential to differentiate into several cell types and can be cultured under defined 
tissue culture conditions in vitro (Estrela et al. 2011). There are many different kinds 
of dental stem cells that have been isolated and characterized: periodontal ligament 
stem cells (PDLSCs), dental pulp stem cells (DPSC´s), stem cells from human 
exfoliated deciduous teeth, stem cells from apical papilla and dental follicle 
precursor cells (Nakahara 2011). PDLSCs seem to have a great potential in 
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regenerative medicine (Tsumanuma et al. 2011). Due to the fact that stem cells 
always need a suitable carrier material, materials science is another important field, 
because it brings regenerative dentistry from the laboratory to the clinic (Mitsiadis et 
al. 2012).  
New alternatives to conventional treatment options are methods based on the 
principles of guided tissue-engineering (GTR), which is based on the principles of 
cell biology and biomaterials and describes a technique to build new tissues to 
replace damaged or diseased tissues (Bartold and Narayanan 1998). There are 
three essential factors for a successful regeneration: a conductive 
scaffold/extracellular matrix, signaling molecules and stem or progenitor cells (Lynch 
et al. 1999). GTR may include the gene therapy (stem cells) and the use of 
biocompatible scaffolds with or without growth factors (Giannobile et al. 2001). 
There are a number of possibilities to treat periodontitis nowadays, but none of them 
appear to regenerate the original tissues totally and as a complex whole (Aljateeli et 
al. 2014), (Soo et al. 2012). In guided tissue regeneration, a barrier membrane is 
placed between the implanted materials and the surrounding soft tissue. This 
anticipates the invasion of gingival epithelial cells and guides the healing process 
(Buser et al. 1994).  A barrier membrane should be degradable, but must not 
degrade uncontrolled. Otherwise it loses its barrier function. Therefore bi-layered 
membranes were developed to improve their stability and avoid cellular invasion. 
Osteoblasts and other periodontal structure building cells, like fibroblasts and 
cementoblasts, should be able to develop along with cells for the oral soft tissues 
(Behring et al. 2008). But only with therapeutic intervention it is possible to stimulate 
regeneration once periodontitis becomes established (Bartold et al. 2000). 
 
1.1.4 Application of materials and scaffolds 
A lot of biomaterials can serve as carrier materials, such as natural or synthetic 
polymers, extracellular matrix, self-assembling systems, hydrogels or bioceramics. 
Scaffolds qualified for transporting stem cells are for example different types of 
collagen (Galler et al. 2011). Growth factors in combination with biocompatible 
matrices play another important role in the reformation of the PDL (Kaigler et al. 
2011). There are a variety of materials that were used to support periodontal 
regeneration so far (table 1).  
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Table 1: Materials used as scaffolds (Palwankar et al. 2014). 
 
Materials have been examined in a range of studies, including bone replacement 
grafts, such as autografts, allografts, xenografts and alloplasts. Guided tissue 
regeneration materials such as barrier materials, including both non-resorbable and 
bioabsorbable membranes have also been investigated in addition to growth factors 
such as bone morphogenetic proteins (BMPs) (Chen et al. 1995). Furthermore, 
bone replacement grafts have been well reviewed. There are many studies that 
investigate the benefit of those materials, like hydroxyapatite or tricalcium 
phosphate. They are easy to place and promise good clinical results (Reynolds et al. 
2003). 
Stem cells (see 1.1.6) need a carrier material for implantation. Carrier materials, 
also called scaffolds, should provide a 3D substratum in which cells can proliferate 
and migrate. The introduced cells produce a matrix and form a functional tissue 
once they are in the scaffold (Pandit et al. 2011). Therefore, the scaffold must have 
a microstructure and chemical composition, which is necessary for normal cell 
growth and function (Oh et al. 2006). Other functions of the matrices include 
structural reinforcement, a barrier to in-growth of surrounding tissues and regulation 
of cell function due to its interaction with certain integrins (Pandit et al. 2011). 
Biocompability and biodegradability are required qualities of a scaffold (Yang et al. 
2001). 
Collagen can also be used as a scaffold/carrier material. A scaffold should provide 
“excellent biocompatibility, controllable biodegradability, appropriate mechanical 
strength, flexibility as well as the ability to absorb body fluids for delivery of nutrients” 
(Khan and Khan 2013). Collagen fulfils these requirements, making it a popular 
biomaterial. Collagen is biocompatible and degradable, making a second surgical 
intervention unnecessary. It has been shown to support angiogenesis (Rothamel et 
Natural Synthetic 
Ceramic Polymers - Polyglycolic, Polyactic 
Hydroxyapatite Polycaprolactone 
Tricalcium Phosphate Co-polymers 
Polymers - Hyaluronic Acid, Polyphosphagonos 
Alginate, Agarose, Chitosan, Nano Calcium Sulphate 
Collagen and Albumin 
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al. 2004), making it an ideal candidate for scaffolds. It is a versatile material and has 
many capabilities including keeping the wound pliable and flexible, promoting the 
development of granulation tissue, minimizing pain and providing mechanical 
protection against physical and bacterial damage (Mitchell and Lamb 1983). The 
collagen protein has a complex hierarchical conformation divided into four 
structures: primary (amino acid triplet), secondary (the α-helix), tertiary (triple helix) 
and quaternary (fibrils) (Gelse et al. 2003). Collagen can be easily modified into 
different physical forms such as powder/particles, gel/solution, membranes, sponges 
and composites (with ceramics) making it easy to apply in dental medicine (Ferreira 
et al. 2012).  
 
1.1.5 Growth factors  
At cellular level, wound healing and regeneration involves a complex sequence of 
events, including cell proliferation and differentiation. These processes are known to 
be modulated by growth factors (Graziani et al. 2006). With better understanding of 
periodontal regeneration process polypeptide growth factors play an increasingly 
important role in research. Growth factors are major growth-regulatory molecules 
and polypeptides, which stimulate cell proliferation in vitro and probably also in vivo 
(Goustin et al.1986). Various types of growth factors, for example epidermal growth 
factors, fibroblast growth factors, insulin-like growth factors, platelet-derived growth 
factors, tumor-derived growth factors and bone morphogenetic proteins were 
described (table 2) (Giannobile et al. 2001). Combinations of these growth factors 
do also exist, such as platelet-rich plasma preparations (Carlson and Roach 2002). 
Growth factors are naturally occurring substances capable of stimulating cellular 
growth, proliferation, healing and cellular differentiation. Usually they are proteins or 
steroid hormones. They play a crucial role in information transfer between cells by 
binding to specific receptors on the surface of target cells. The chemical identity, 
concentration, duration and context of these growth factors contain information that 
dictates cell fate (Tayalia and Mooney 2009). 
Within the complex “wound healing cascade”, GFs are known to play a central role 
in information transfer between a wide range of cells and their ECM. They stimulate 
endogenous repair mechanisms by providing the right signals to cells. This leads to 
a functional restoration of damaged or defective tissues (Chen et al. 2010). 
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Table 2: Functions of the main GFs in relation to different healing processes (Ramos-Torrecillas 
et al. 2014, Sigurdsson et al. 1997). 
Growth factor Most representative function 
Platelet-derived growth factor Chemotaxis, inducing cells to migrate to the wound bed. 
Transforming growth factor-ß 
Cell proliferation inhibition, increase in synthesis of 
extracellular matrix and inhibition of degradation; it 
favors neutrophil and monocyte chemotaxis, although its 
specific action also depends on the cell environment. 
Bone morphogenetic proteins 
Repair of epidermis in more superficial layers of skin and 
inhibition of keratinocyte proliferation in deeper layers, 
ability to induce bone formation. 
Fibroblast growth factor 
Mitogenic for endothelial cells, fibroblasts, 
chondroblasts, and osteoblasts; it favors angiogenesis. 
Epidermal growth factor 
Proliferation and mobility of fibroblasts and 
keratinocytes. 
Vascular endothelial  
growth factor 
Angiogenesis and increase in capillary permeability. 
Insulin-like  
growth factor 
Favoring reepithelization and production of granulation 
tissues. 
Interleukins 
General proinflammatory function, regulation of 
immunological cell growth and/or differentiation. 
 
 
1.1.6 Dental stem cells 
Stem cells are immature progenitor cells with regenerative potential. Based on a 
process of asymmetric mitosis, in which progenitor stem cells and daughter cells 
occur, they are capable for cell renewal and multi-lineage differentiation (Estrela et 
al. 2011). Stem cells can self-renew and produce different cell types. Therefore, they 
can offer new possibilities to regenerate missing tissues and treat diseases. In the 
field of dentistry, adult mesenchymal stem cells (MSCs) represent the most 
promising stem cells. They have been identified in several oral and maxillofacial 
tissues (Egusa et al. 2012). MSCs are the most versatile stem cells among all adult 
stem cells, because they can change their phenotype easily during differentiation. 
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They are also available in a large number and can be isolated and cultured relatively 
easy (Vemuri et al. 2011). 
Recent studies showed that oral tissues are a rich source of stem cells. This might 
bring new opportunities, because those tissues are easily accessible for dentists. 
Once extracted, the removed tissue samples can be used for in vitro cell cultivation 
and play an important part in tissue engineering (Langer and Joseph 1993). 
Autologous stem cells can be embryonic or adult stem cells. Embryonic stem cells 
originate from embryonic tissues, like placenta or umbilical cord (Nadig 2009), which 
are pluripotent because they can develop into all types of cells from all three 
germinal layers. The adult stem cells, which are mostly multipotent, can only 
differentiate into a limited number of cell types (Egusa et al. 2012).  
Only 30 years ago Melcher published that the three cell populations of the 
periodontium (cementoblasts: building cementum; fibroblasts: building periodontal 
ligament and osteoblasts: building alveolar bone) are all derived from one population 
of stem cells (Melcher 1985). Melcher also determined that only cells from the 
periodontal ligament can synthesis and secrete cementum and at the same time 
attach newly-formed collagen fibers.  
 
 
Figure 4: Sources of adult stem cells in the oral and maxillofacial region. BMSCs: bone marrow-
derived MSCs from orofacial bone; DPSCs: dental pulp stem cells; SHED: stem cells from human 
exfoliated deciduous teeth; PDLSCs: periodontal ligament stem cells; DFSCs: dental follicle stem cells; 
TGPCs: tooth germ progenitor cells; SCAP: stem cells from the apical papilla; OESCs: oral epithelial 
progenitor/stem cells; GMSCs: gingiva-derived MSCs, PSCs: periosteum-derived stem cells; SGSCs: 
salivary gland-derived stem cells (Egusa et al 2012). 
 
  
Introduction 
 
11 
 
Adult stem cells can self-renew and differentiate to maintain healthy tissues and 
repair injured tissues. They can be found in many oral tissues and many sources 
have been found in the maxillofacial region (figure 4). It is believed that the adult 
stem cells reside in a specific area of each tissue, called “stem cell niche”. A lot of 
these stem cells appear in mesenchymal tissues, why they are called mesenchymal 
stem cells (MSCs) (Egusa et al. 2012). MSCs are adherent to tissue-cultured-
treated plastic, which is a well-established method to identify those (Horwitz et al. 
2005). Another criterion for identifying stem cells is the expression of certain cell 
surface markers like CD105, CD73 and CD90 and a lack of the expression of CD45, 
CD34, CD14 or CD11b, CD79a or CD19 and HLA-DR surface molecules. Further, 
they must be able to differentiate to osteoblasts, adipocytes and chondroblasts in 
vitro (Dominici et al. 2006). 
MSCs are the most promising stem cells for clinical applications. They were initially 
found in bone marrow first and can be found in several oral and dental tissues yet, 
like orofacial bone, dental pulp, periodontal ligament etc. (figure 5) (Ding et al. 
2011). The regenerative potential of some dental tissues can be observed. The 
periodontal tissues are able to regenerate by a natural process after an orthodontic 
treatment. Another example is the building of reparative dentin after a root canal 
treatment or a deep carious lesion (Cox et al. 1992).  
Periodontal ligament stem cells (PDLSCs) are part of the MSCs and can be isolated 
from extracted teeth. In animal models it has been established that PDLSCs can 
regenerate any kind of periodontal tissues (cementum, periodontal ligament and 
alveolar bone) (Seo et al. 2005).  
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Figure 5: Stem cell differentiation/role of periodontal stem cells in periodontal regeneration. 
Progenitor stem cells can differentiate into cementoblasts, fibroblasts or osteoblasts (Bartold et al. 
2006). 
 
PDLSCs need a suitable scaffold being implanted, such as hydroxyapatite/tricalcium 
phosphate (HA/TCP), to induce the formation of cementum, periodontal ligament 
and bone in vivo (Gronthos et al. 2000).  
Studies showed that it is also possible to regenerate other tissues such as skin, 
cartilage, bone, pancreas, etc. with the help of stem cells (Persidis 1999). Therefore, 
it seems achievable that autologous periodontal ligament stem cells, cultured within 
a suitable scaffold in combination with growth factors presented in autologous blood, 
will lead to new periodontal tissue attachment (Bartold et al. 2006).  
An example for testing the potential of PDLSCs in vivo is a study with rats. Cultured 
human periodontal ligament stem cells have been implanted into surgically created 
periodontal defects in immunosuppressed rats. The result was a “periodontium-like-
structure” consisting of cementum, inserting periodontal ligament and alveolar bone 
(Seo et al. 2004). Many studies have been performed with minipigs or beagles 
(Lang et al. 1997, Pieri et al. 2009, Kawaguchi et al. 2004). 
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1.2 Purpose of this study  
In this study we used a minipig model to analyze the potential of different collagen 
carrier materials with or without periodontal ligament stem cells or a growth factor 
cocktail for periodontal regeneration in class II furcation defects. The aim of the 
present study was to examine the regenerative potential of a) different collagen 
support versus control, b) different collagen support +/- a growth factor cocktail (GF) 
and c) a collagen powder versus collagen powder + periodontal ligament stem cells 
(PDLSCs) comparatively in a large animal model.  
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2 MATERIALS AND METHODS 
2.1 Materials 
A collagen membrane, a collagen matrix and a collagen powder were implanted 
solely or combined with either dental stem cells or a growth factor cocktail into class 
II furcation defects. All defects were covered with a semipermeable membrane 
(bredent medical, angiopore selective permeable membrane, Senden, Germany) 
with a thickness of 0,3 mm – 0,5 mm and a size of 35 mm × 45 mm (REF: 
AP053545). The membrane consisted of compact collagen fibre structures and 
offered a combination of safe barrier function and enhanced angiogenesis. The 
compact fibre structure hindered the invasion of gingival epithelial cells to avoid an 
epithelial downgrowth, although the micro-fibrillary angiopores served as guidance 
for the infiltration of blood vessels, which were important for the regeneration 
process. 
 
2.1.1 Collagens 
Three different collagen materials were used in this study. The collagen membrane 
(DOT, Rostock, Germany) consisted of 1% collagen mixed with 
hydroxylapatit/tricalcium phosphate (BONITmatrix) in a mass relation of 4:1. 
Hydroxylapatit and tricalcium phosphate have been investigated thoroughly in 
intrabony and furcation defects (Saffar et al. 1990), (Bowen et al. 1989). 
BONITmatrix is a synthetic resorbable bone graft material. It consists of 
hydroxyapatit (HA) and ß-tricalciumphosphat (ß-TCP) in the proven ratio of 60/40. A 
specific particularity is the incorporation of biological active silicon in form of a silicon 
dioxide xerogel. The material is characterized by an interconnecting pore system in 
the nano- and micrometer range. Biological fluids can diffuse due to the high 
capillarity and the adsorptive capacity of the surface and the binding of growth 
factors leads to osteogenesis. 
Furthermore, a collagen matrix (Bioserv, Rostock, Germany) was applied. 
Therefore, collagen from jellyfish Rhopilema spec., a biopolymer with natural ECM 
(extracellular matrix) characteristics and low risks for BSE was used in this study. 
Collagen is a highly conserved protein across multiple species and can be obtained 
from different sources, like bovine or porcine skin. However, there is still the problem 
of potential bovine spongiform encephalopathy (BSE) or transmissible spongiform 
encephalopathy (TSE). To avoid this risk jellyfish from marine sources, precisely 
from jellyfish Rhopilema spec. was chosen to design a 3D scaffold for tissue 
engineering applications. In earlier tests these scaffolds promoted excellent cell 
Materials and Methods 
 
15 
 
growth, biocompatibility and suitable degradation characteristics (Hoyer et al. 2014). 
A jellyfish contains more than 95 % water. When they are dried, more than 40 % of 
their dry weight is collagen, making them an excellent source of collagen (Miura and 
Kimura 1985).   
Also, a commercially available collagen powder was used as filling material and 
carrier for the dental stem cells. The collagen powder was provided by MedSkin 
Solutions Dr. Suwelack AG, Billerbeck, Germany. The material was obtained from 
bovine skin and either implanted solely or used as a carrier material for the 
periodontal ligament stem cells. The collagen powder in spherical shape was easy 
to apply and consisted of the collagen types I, III and V.  
 
2.1.2 Periodontal ligament stem cells  
The stem cells used in this study were periodontal ligament stem cells – PDLSCs. 
Periodontal ligament stem cells are part of the mesenchymal stem cells (Acharya et 
al. 2010). PDLSCs can produce cementum- and periodontal-like structures in vivo. 
Therefore, they can play an important role in regenerative dentistry (Mrozik et al. 
2010). Under standard growth conditions, i.e. 10 % fetal bovine serum (FBS) - 
containing medium, PDLSCs can be isolated from the periodontal ligament and 
cultured in a culture dish. Periodontal ligament stem cells are heterogeneous, 
adherent to plastic and do have a fibroblast-like morphology (Vemuri et al. 2011). 
PDLSCs do have the ability to generate clonogenic adherent cells (Seo et al. 2004). 
 
2.1.2.1 Isolation of PDLSCs 
The PDLSCs were isolated and cultured according to Haddouti´s protocol with slight 
modification (Haddouti et al. 2009). In the first surgery, the teeth were extracted and 
surrounding tissues were taken from a total of 15 minipigs. The extracted teeth plus 
the surrounding tissues were used to isolate and culture mesenchymal stem cells. 
All surgical procedures were carried out under aseptic conditions. All extracted teeth 
and viable materials were treated repeatedly with a rinsing solution, consisting of 
cooled phosphate buffered saline (PBS, 20 ml PBS 1x) and antibiotics (200 μl 
penicillin/streptomycin 1x, PenStrep, gibco, Grand Island, NY, USA) to avoid 
bacterial contamination. The samples were transported in DMEM-F₁₂ (gibco, Grand 
Island, NY, USA) including 2 % antibiotics (PenStrep, gibco, Grand Island, NY, 
USA). They had to be kept on a constant temperature of + 4 °C.  
In the laboratory, PDL tissues were separated from the root using a scalpel and 
were minced to the smallest size possible under aseptic conditions. The tissue 
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samples were incubated in DMEM-F₁₂ (gibco, Carlsbad, USA) with 2.5 mg/ml of 
dispase (Sigma-Aldrich, St. Louis, USA) for 1.5 hours at 37 °C and 5 % CO₂. After 
incubation, the tubes were centrifuged at 400 g for 4 minutes at 4 °C. The 
supernatant was discarded, the remaining tissues transferred into a cell culture flask 
(greiner-bio one GmbH, Kremsmünster, Austria) and 3 ml cell culture medium of 
DMEM-F₁₂ including 10 % fetal bovine serum (BIOCHROM, Berlin, Germany) and 
1 % PenStrep (gibco, Carlsbad, USA) was added. The cell culture flasks were 
incubated at 37 °C and 5 % CO₂.  
The following day, floating cells were removed and the medium was replaced with 
fresh medium. All samples were checked for bacterial contamination under a light 
microscope. Flasks without bacterial contamination were incubated for 1 – 2 weeks 
and attached cells were fed with fresh medium every 3 days. The cells were cultured 
in DMEM-F₁₂ and passaged with trypsin (gibco, Grand Island, NY, USA). Daily 
control of the samples was necessary. Cell culture stocks were frozen. Therefore, 
the cells were trypsinated with 2 ml trypsin (gibco, Grand Island, NY, USA) and 
centrifuged at 400 g for 1 minute at 4 °C. Cryotubes were used to freeze cell 
passages with FBS (fetal bovine serum, BIOCHROM, Berlin, Germany) and 10% 
DMSO (dimethyl sulfoxide, Carl Roth GmbH, Karlsruhe, Germany) at -70 °C. For 
reimplantation 10⁶ cells of passage (p) 3 – 4 were applied.  
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2.1.2.2 Characterization of PDLSCs 
Periodontal ligament stem cells (figure 6) are a unique population of the 
mesenchymal stem cells and can be characterized by the expression of different 
surface markers like CD 29, CD 44, CD 90 and many more (table 3).  
 
Table 3: Characteristics of human dental tissue and gingiva-derived MSCs. PDL: periodontal 
ligament; differentiation lineages: dent (dentinogenic lineage), mes (mesodermal lineage), (Egusa et al. 
2012). 
Stem 
cells 
CD antigen expression Other 
representative 
markers 
In vivo tissue 
formation 
capacity 
positive negative 
 
PDLSCs 
 
CD9,     
CD10, 
CD13,   
CD29, 
CD44,   
CD49d, 
CD59,   
CD73, 
CD90,   
CD105 
CD106, 
CD146, 
CD166 
 
 
CD31, CD34, 
CD45 
 
STRO-1, 
Scleraxis 
 
dent 
(cementum, PDL), 
 
mes (alveolar bone) 
 
 
  
Figure 6: Light microscopically pictures of periodontal ligament stem cells.  
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The periodontal ligament stem cells were characterized by the presenting specific 
surface molecules. For characterization, the stem cells (p4) were trypsinated with 
2 ml trypsin (gibco, Grand Island, NY, USA) and 10 ml of DMEM-F₁₂ (gibco, 
Carlsbad, USA). Following, 10 % FBS (BIOCHROM, Berlin, Germany) was added to 
deactivate the trypsin. Then, the cells were centrifuged at 300 g for 10 minutes at 
21°C. The dissolved cells had to be washed twice to eliminate any remaining FBS.  
The cell pellet was then dissolved in a 99 µl FACS buffer consisting of 1 % PBS with 
a pH of 7, 2 and 0, 2 % sterile bovine serum albumin (BSA). Afterwards, 1 µl of the 
respective antibodies was added. The solution had to be cooled at 4°C for 30 
minutes.  
Afterwards, 1 ml of the FACS buffer was added and all was centrifuged at 300 g for 
10 minutes at 4°C. The supernatant was removed and a further 100 µl FACS – 
buffer added. Next, the flowcytometrical measurement started. 
The flow cytometer (BD Accuri C6; Becton-Dickinson, Mansfield, MA, USA) 
validated the presence of the earlier named antibodies.  
 
2.1.3 Growth factors 
The growth factor cocktail used in this study was provided by DOT (DOT, Rostock, 
Germany). The growth factors were dissolved in 0, 9 % sodium chloride, resulting in 
a concentration of 2 mg/ml, handed in 1 ml syringes. One syringe contained a 
mixture of VEGF, b-FGF, IGF-1 and TGF-ß1 (table 4). Per defect 0, 15 ml were 
used with an amount of 0, 3 mg GF.   
 
Table 4: Content of growth factors in 10 mg lyophilisat. 
Sample 
Total weight 
of lyophilisat 
[g] 
TGF-ß3 
[pg] 
VEGF 
[pg] 
b-FGF 
[pg] 
IGF-1 
[pg] 
TGF-ß1 
[pg] 
648 0.1520 0 799.953 159.448 62.297 87683.92 
881 0.2243 0 893.536 323.861 45.206 260118.88 
268 0.2933 0 491.804 440.465 15.217 103345.92 
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There are different kinds of growth factors that stimulate different cell 
differentiations. In this study a mix of diverse growth factors was used (table 5).  
VEGF means vascular endothelial growth factor. VEGFs stimulate vasculo- and 
angiogenesis (Koch et al. 2011).  
FGF stands for fibroblast growth factors. More precisely, b-FGF means basic 
fibroblast growth factor. They are also mediating the formation of new blood vessels 
(Itoh and Ornitz 2011). 
IGF-1 is the insuline like growth factor. It binds to its specific receptor which is 
present on many cell types in many tissues. It is a stimulator of cell growth and 
proliferation and a potent inhibitor of programmed cell death (Pollak 2012). 
The fourth component of this mixture is TGF, equivalent to transforming growth 
factor. TGFs are proteins that control proliferation, cellular differentiation and other 
functions in most cells (Dobaczewski et al. 2011). More precisely, TGF-β1 plays an 
important role in cell proliferation, matrix formation and odontogenesis. Furthermore, 
it also affects growth, collagen turnover and the differentiation of apical papilla cells 
(Chang et al. 2015). 
 
Table 5: Content of GF per syringe. 
Charge VEGF [pg] b-FGF [pg] IGF-1 [pg] TGF-ß1 [pg] 
881 178.7 64.8 90.2 52023.8 
 
2.1.4 Material testing prior to implantation 
Prior to the implantations, several testings with the stem cells were necessary. Stem 
cells need a suitable carrier material for implantation. Also, a scaffold is important to 
guarantee that the cells remain in place. Those scaffolds have to provide a 3D 
substratum on which cells can proliferate and migrate (Ponticiello et al. 2000). 
Therefore, the PDLSCs were paired with the collagen matrix, a collagen hydrogel 
and the collagen membrane. The stem cells were transferred into these materials 
overnight, then after 24 hours a life-death-stain was performed to evaluate the 
survival rate of the stem cells.  
Another carrier was also tested. The collagen powder (MedSkin Solutions Dr. 
Suwelack AG, Billerbeck, Germany) was paired with the stem cells. Therefore, the 
acid pH value (pH ~ 4-5) of the collagen powder was buffered to a neutral pH value, 
because stem cells would not survive in an acid pH value (Monfoulet et al. 2014). 
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A test series with different buffers (HEPES and sodium hydrogen carbonate 
(NaHCO 3) followed (table 6). For a 24 hour testing, the stem cells were put into the 
above named buffers overnight:  
 
Table 6: Test series with different buffers, the collagen powder and medium. 
Test mixture  
A 0.1 g collagen powder + 400 µl medium + 400 µl 2 % NaHCO3 
B 2 x 0.1 g collagen powder + 300 µl medium + 500 µl 2 % NaHCO3 
C 0.1 g collagen powder + 800 µl HEPES 
 
The samples were incubated at 4°C for 30 minutes and subsequently for another 24 
hours at 37°C. Safranin was added. Afterwards, the cells were trypsinated and 
centrifuged at 400 g for 4 minutes at 4°C and 1900 rpm. The supernatant was 
retarded and the cell pellet dissolved in 160 µl HEPES. Cells were counted and 
evaluated under a fluorescence microscope.  
Finally, a potassium buffer was tested. It turned out to be the most suitable and was 
used in the following implantations. Therefore, per defect 0, 05 g collagen powder, 
100 µl potassium buffer and 300 µl medium were applied.  
Prior to the implantations, the stem cells were trypsinated and counted in a 
Neubauer counting chamber (BRAND, Wertheim, Germany) for a precise cell 
concentration. After centrifugation the cell pellet was dissolved in medium without 
FBS. In the laboratory and under aseptic conditions, a 24 wells microplate was 
prepared. Each well of one row contained the following materials:  1. row: 0, 05 g 
collagen powder, 2. row: 100 µl potassium buffer, 3. row: 300 µl medium without 
FBS and stem cells. 
For the transport to the operating room the microplates had to be constantly kept on 
ice. Chairside, the prepared materials were mixed. The buffer and the collagen 
powder had to be mixed first to eliminate the acid pH value. Finally, the stem cells 
were added and the mixture was applied into the furcation defect with the help of a 
sterile spatula. 
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2.2 Methods  
2.2.1 Experimental design of animal research 
Fifteen “Göttinger” miniature pigs (22 ± 3 months old), weighing 35 ± 10, 8 kg, each 
exhibiting a fully erupted permanent dentition, were used for this study. The minipigs 
were housed under conventional conditions with free access to water. Diet had to be 
modified to support wound healing. The study protocol was approved by the 
appropriate local authority (German Decree on the Reporting of Laboratory Animals 
7221.3-1.1-075/11, Regional Authority for Agriculture, Food Safety and Fisheries, 
State of Mecklenburg-Western Pomerania, Germany). All surgical procedures were 
performed under anaesthesia. In addition to general anaesthesia the animals 
received a further local anaesthesia. All efforts were made to minimize animal 
suffering. The perioral tissues and the gingival were disinfected with povidone iodine 
and the perioral hair was cut. The 1st and 2nd premolar of each animal were 
extracted in both quadrants of the lower jaw. The extracted teeth were used for 
isolating and culturing stem cells. 90 days after tooth extraction class II furcation 
defects were created at the 3rd premolar and 1st molar in the mandible on both sites. 
The defects were randomly filled with different treatment groups: 
• Group I   - control, 
• Group II   - collagen membrane, 
• Group III   - collagen membrane plus growth factors, 
• Group IV   - collagen matrix, 
• Group V   - collagen matrix plus growth factors, 
• Group VI   - collagen powder, 
• Group VII  - collagen powder plus stem cells. 
Afterwards, all defects were covered with a semipermeable membrane and a 
polychrome sequential labeling was performed 14, 28 and 84 days after the 
replantation. Therefore, three different fluochromes were administered by 
subcutaneous injection: xylenol orange (6 %, 2-5 g/animal), calcein green (1 %, 0.8-
1.5 g/animal) and alizarine complexone (3 %, 1-1.5 g/animal, all from Thermo Fisher 
Scientific, Waltham, USA). To ensure a good wound healing, a clinical examination 
of the animals occurred simultaneously. The animals were sacrificed after 120 days 
of healing followed by a histological assessment (figure 7). 
This study was part of a third-party funded project supported by the state of 
Mecklenburg-Western Pomerania. As the author was still a student by then, her 
tasks were to assist in the surgeries (surgeons were Dr. Daniel Welly and Malte 
Scholz, Department of Operative Dentistry and Periodontology, University of 
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Rostock, Rostock, Germany), the isolation and culturing of the periodontal ligament 
stem cells, histological assessment of the specimens and statistical analysis.  
 
 
 
Figure 7: Experimental workflow. Within 210 days the total procedure occurred, from extracting teeth 
over implantation to histological assessment of the specimens. 
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2.2.2 Anaesthesia  
All surgical procedures were carried out under aseptic conditions and general 
anaesthesia. Prior to each surgical intervention, the animals received a pre-
medication with ketamine 10 %, (Pfizer AG, NY, USA) plus 1.5 ml midazolam 
(Sanochemia Pharmazeutika AG, Neufeld, Österreich) by intramuscular injection. 
Intravenous access was established through the ear vein. For muscle relaxation, an 
induction was continued by the injection of 0.25 ml – 0.4 ml pancuronium (Organon 
Teknika, Eppelheim, Germany). Following oral intubation anaesthesia was 
continued by inhalation of isoflurane (AbbVie AG, Baar, Switzerland) and injection of 
0.5 ml - 0.8 ml/min fentanyl (Janssen - Cilag, Neuss, Germany). The administration 
of oxygen was about 1, 5 l/min. 
After the beginning of the general anaesthesia, the perioral hair was cut and the 
perioral tissues and the gingiva were disinfected with povidone iodine 
(Betaisodona ®, Mundipharma GmbH, Limburg an der Lahn, Germany). 
Additionally, the animals received a further local anaesthesia (Ultracain D-S forte, 
1:100 000, 2 ml, Sanofi-Aventis Deutschland GmbH, Germany). Intraoperative, 
antibiotics were administered as ampicillin/sulbactam 1000 mg/500 mg i.v. (HEXAL 
AG, Holzkirchen, Germany). For postoperative analgesia treatment the animals 
received an oral Metacam ® - suspension (15 mg/ml) with a dose of 2.7 ml/100 kg 
body weight and synulox 250 mg (Pfizer AG, NY, USA). 
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2.2.3 Extractions 
The 1st and 2nd premolars of the minipigs were extracted in both quadrants of the 
mandible. The teeth were loosened with a lever and pulled with extraction forceps. 
The periodontal ligament of the extracted teeth was obtained to isolate PDLSCs. All 
extracted teeth and viable materials were treated repeatedly with a rinsing solution 
(table 7), consisting of cooled phosphate buffered saline (PBS, 20 ml PBS 1x) and 
antibiotics (200 μl penicillin/streptomycin 1x, PenStrep, gibco, Grand Island, NY, 
USA). The rinsing was necessary to minimize bacterial contamination. The samples 
were transported in a transport medium (DMEM-F₁₂, gibco, Grand Island, NY, USA) 
including 2 % antibiotics (PenStrep, gibco, Grand Island, NY, USA). The samples 
had to be kept on a constant temperature of + 4 °C.  
 
Table 7: Rinsing solutions for extractions. Six different rinsing solutions were used in order to delete 
excessive blood and bacteria. Finally the samples were transported in the transport medium to the 
laboratory.  
 
Rinsing solution Antibiotics 
50 ml PBS 1x 
 50 ml PBS 1x         + 500 μl Penicillin/Streptomycin  (1x) 
20 ml PBS 1x         + 200 μl Penicillin/Streptomycin  (1x) 
20 ml PBS 1x         + 2 ml    Penicillin/Streptomycin  (10x) 
20 ml PBS 1x         + 200 μl Penicillin/Streptomycin  (1x) 
20 ml PBS 1x         + 200 μl Penicillin/Streptomycin  (1x) 
Transport medium 
 20 ml DMEM-F12   + 400 μl Penicillin/Streptomycin  (1x) 
 
2.2.4 Implantations 
In the second surgical intervention, class II furcation defects were created at the 3rd 
premolar and 1st molar bilaterally of the mandible. Initially, a mucoperiosteal flap was 
raised with the help of a raspatory. The periodontal furcation defects were created 
with a bud burr (Henry Schein dental Deutschland GmbH, Langen, Germany). The 
bottom of the created furcation defects were marked with a notch for later 
histological evaluation. Subsequently, the defects were randomly filled with the 
following materials: Group I - control, Group II - collagen membrane, Group III - 
collagen membrane plus growth factors, Group IV - collagen matrix, Group V - 
collagen matrix plus growth factors, Group VI - collagen powder, Group VII - 
collagen powder plus stem cells (table 8). With a sterile Heyman type spatula (Henry 
Schein dental Deutschland GmbH, Langen, Germany) all materials were filled into 
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the furcation defects. All defects were covered with a 35 X 45 mm semipermeable 
membrane (bredent medical, angiopore selective permeable membrane, Senden, 
Germany) and closed with a mucoperiosteal flap using absorbable sutures 
(ETHICON, VICRYL, 3-0, Polylactin 910, SH-1 plus) to ensure a transmucosal 
healing for 120 days (figure 8).  
 
Table 8: Overview of implanted materials. The furcation defects were created at the 3rd premolar 
(P3) and 1st molar (M1) and filled with below named materials. * defects treated with particles were not 
part of this study. 
minipig 
3. quadrant 4. quadrant 
P3 M1 P3 M1 
207627 collagen membrane control hydrogel collagen matrix 
208054 collagen membrane control collagen matrix hydrogel 
207574 
collagen membrane 
+ GF 
control 
hydrogel 
+ GF 
collagen matrix 
+ GF 
207882 
collagen membrane 
+ GF 
control 
collagen matrix + 
GF 
hydrogel 
+ GF 
208178 
collagen powder + 
2,9 x 10⁵ cells 
collagen powder + 
3,8 x 10⁵ cells 
collagen matrix collagen membrane 
208380 collagen powder collagen powder 
collagen powder + 
2,2 x 10⁵ cells 
collagen powder + 
2,9 x 10⁵ cells 
208248 
collagen powder + 
6,4 x 10⁵ cells 
collagen powder + 
5,6 x 10⁵ cells 
collagen powder + 
2,3 x 10⁶ cells 
collagen powder + 
1 x 10⁶ cells 
209356 abscess abscess control control 
208196 
collagen membrane      
+ GF 
collagen membrane collagen matrix collagen matrix 
207733 
collagen membrane      
+ GF 
collagen membrane collagen membrane 
collagen membrane 
+ GF 
211715 collagen powder collagen powder 
collagen powder + 
cells + particles * 
collagen powder + 
cells + particles * 
211343 
collagen powder + 
cells+ particles* 
collagen powder + 
cells+ particles* 
abscess abscess 
211717 collagen powder collagen powder 
collagen powder + 
cells+ particles* 
collagen powder + 
cells+ particles* 
305148 
collagen membrane      
+ GF 
collagen membrane 
+ GF 
collagen membrane collagen membrane 
305068 
collagen matrix 
+ GF 
collagen matrix 
collagen matrix 
+ GF 
collagen matrix 
+ GF 
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Figure 8: Implantations. A: at surgery: arterial oxygen saturation was measured with a method called 
pulse oximetry, B: the minipig was covered with sterile blankets and perioral tissues were disinfected 
with beta isodoma, C: 3rd quadrant, mucoperiostal flap mobilized, furcation defects visible, D: 
angiopore selective permeable membrane before placing.   
 
2.2.5 Polychrome sequential labeling 
The technique of polychrome sequential labeling was used in order to 
microscopically investigate the state of new bone formation and remodeling 
processes at different time intervals (figure 9). Therefore, three different fluochromes 
(Thermo Fisher Scientific, Waltham, USA) were administered by intravenous 
injection 14, 28 and 84 days after implantation: xylenol orange (6 %, 2-5 g/animal), 
calcein green (1 %, 0.8-1.5 g/animal) and alizarine complexone (3 %, 1-
1.5 g/animal). Thus, the animals were sedated by ketamin 10 %. Simultaneously, a 
clinical examination of the animals was performed to ensure a good wound healing 
and to check the medical condition of the animals. 
A B
C D
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Figure 9: Fluorescence microscopy of furcation defect. A: different fluochromes mark bone 
formation at different time intervalls, B: newly formed cementum and the desmodont is visible. 
 
2.2.6 Histological analysis 
Histological samples were used to evaluate the healing processes. For the 
production of the samples, the animals were euthanized by an overdose of 
thiopental (Ospedalia AG, Hünenburg, Schweiz) 120 days after the last surgery. 
Therefore, a premedication with ketamine (Pfizer AG, NY, USA) was applied. The 
oral tissues were fixed by perfusion with 10 % buffered formalin (Helm Austria 
GmbH, Wien, Austria) administered through the carotid arteries. The mandible was 
exarticulated and cut into segments. It was fixed in formafix (Formafix Switzerland 
AG, Hittnau, Switzerland) 4 % for 7 days and kept in ethanol for a further 14 days. 
The segments were then block-embedded in technovit® (Heraeus, Hanau, 
Germany) 7200 VLC over 28 days. Next, the specimens were cut into 250 µm-thick 
sections in the sagittal direction using a saw microtome (EXAKT Advanced 
Technologies GmbH Norderstedt, Germany) under permanent cooling. Finally, the 
specimens were grinded down to 15 μm and stained with toluidine blue. In an 
observer blinded fashion, the specimens were evaluated with respect to 
morphologic and morphometric aspects. A light optical microscope (Carl Zeiss, Axio 
Imager M2, Jena, Germany) with scanning stage was used. With the help of the 
microscope all samples were scanned at a magnification of 20 using an Axiocam 
MRC5 digital microscope camera (Carl Zeiss Microscopy GmbH, Jena, Germany).    
The evaluation and measurement of the samples occurred with the help of 
AxioVision (microscope software, Carl Zeiss Microscopy GmbH, Jena, Germany). 
The bottom of the defects showed the notches. In case the notches could not be 
identified in the histological samples, the fluochrome labeling was used to determine 
the defect area. Due to the fact that fluorescent colors accumulate in calcified 
tissues with a higher formation rate (Cheng et al. 2013), newly formed tissues could 
be identified with the fluochrome labelling. The visualization of the newly formed 
A B
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tissues was observed via a fluorescence microscope (Carl Zeiss, 4×, Axiovert 40 
CFL, Axiocam MRC5, Jena, Germany) with a filter of 490 – 520 nm especially 
excitating the calcein green fluorescence. With the help of AxioVision each tissue 
was marked with its specific color in every specimen. The measured lengths were 
summed up and the percentage for every measured tissue of the total defect length 
was calculated (e.g. the new attachment formation for the control group is 13.0 ± 
18.0 %, this means 13 % of the total defect length). Based on the results a statistical 
analysis followed. The total defect length was defined as the distance along the root, 
from one notch to the other (= 100 %). The total defect length was comprised by 
different tissues such as new attachment (NA), connective tissue (CT), epithelial 
attachment (EA) and new cementum (NC). AxioVision SE64 Rel. 4.8 (microscope 
software, Carl Zeiss Microscopy GmbH, Jena, Germany) was used for the 
histomorphometric measurement. Each tissue was marked by different colours (NA 
– green, CT – yellow, EA – red, NC – blue, see figure 11).  
The histological assessment of the specimen occurred in several steps. First, the 
defect area was determined with the help of the fluorescent colors (figure 10).  
 
 
Figure 10: Fluorescence microscopy of furcation defects. Red line marks the margin between the 
older and newly formed bone; red line represents bottom of furcation defects. The distinction between 
older (low fluorescence) and newly formed bone (highly fluorescent) is visible; defect area is marked by 
fluorescent tissues. 
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A systematic drawing illustrates a furcation defect and the different tissue types and 
its specific colors used in this study (figure 11). Figure 12 shows the measured 
tissues in a histological picture of a class II furcation defect. The three main tissue 
types that were measured in the histological specimens are shown in figures 13-15.  
 
 
Figure 11: Drawing of furcation defect with measured sections for histometric assessment. AB: 
alveolar bone, bod: bottom of defect, C: cementum, NC: newly formed cementum, NA: new 
attachment, EA: epithelial attachment, R: root (dentin), CTA: connective tissue attachment, NB: newly 
formed bone, B) measured sections in histological sample: green: NA, yellow: CTA, red: EA, not in this 
picture: turquoise: CTA+NC, white: concrement, purple: old attachment. 
 
 
 
Figure 12: Representation of the different tissues marked in specific colour and measured 
sections. green: NA, yellow: CTA, red: EA, not in this picture: turquoise: CTA+NC, white: concrement, 
purple: old attachment. 
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Figure 13: New attachment (NA). The NA is marked by newly formed collagen fibers inserting into 
newly formed cementum along the root surface. New cementum is rich in fibers (see grey lines). The 
PDL is marked by directional collagen fibers inserting into newly formed cementum. C: cementum, NC: 
newly formed cementum, PDL: newly formed periodontal ligament (collagen fibers), NB: newly formed 
alveolar bone; scale on micrograph indicates original dimensions in µm. 
 
 
Figure 14: Connective tissue attachment (CTA). The CTA is marked by undirected collagen fibers, 
blood vessels and fibroblasts. The new cementum (NC) is cellular and marked by filamentary darker 
structures. NC: newly formed cementum, NB: newly formed bone, scale on micrograph indicates 
original dimensions in µm. 
 
 
Figure 15: Epithelial attachment (EA). The EA, also called long junctional epithelium, is the primary 
pattern of healing that occurs after periodontal debridement, there is no periodontal ligament or bone 
formation. It is marked by spherical cells building long septa fencing in the connective tissue. NC: new 
cementum, R: root (dentin), CTA: connective tissue attachment, scale on micrograph indicates original 
dimensions in µm. 
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2.2.7 Statistics 
The Kolmogorov-Smirnov test was used to prove the normal distribution of the data. 
The ANOVA test followed to determine the significant differences between the data 
of the measured defects’ lengths. The level of statistical significance was set at p ≤ 
0.05. The data was evaluated with Excel (Microsoft Excel 98, Microsoft Co.) and 
presented as mean ± SD. The graphs were also crafted with Excel.  
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3 RESULTS 
The aim of this study was to examine the regenerative potential of various collagen 
materials with or without dental stem cells or growth factors in periodontal class II 
furcation defects in minipigs. Therefore, the materials were implanted randomly in a 
total of 60 defects. Prior to the implantations, several pre-tests were done.  
 
3.1 Material testings prior to implantations 
To find an appropriate carrier material for the periodontal ligament stem cells, 
several preliminary studies were performed. The PDLSCs were paired with the 
collagen matrix, a collagen hydrogel and the collagen membrane. 24 hours later a 
Live/Dead staining was performed. With the help of Live/Dead stainings a 
differentiation between living and dead cells (Moreau et al. 2009) was possible. 
Dead cells were stained red (figure 16). It turned out that most of the cells did not 
survive in combination with the initially tested scaffolds.  
 
 
Figure 16: Material testing prior to implantations. The above named materials were not appropriate 
to be a carrier for the PDLSCs, A: collagen matrix: stem cells died after 24 hours, Live/Dead staining, 
B: overlay of Live/Dead staining and light microscope image of collagen hydrogel and stem cells, most 
of the cells died after 24 hours, C: collagen membrane: stem cells died after 24 hours. 
 
Further materials were tested in combination with the PDLSCs. The collagen 
powder (see 2.1.1) appeared to be a potential carrier material for dental stem cells. 
The acid pH value of the collagen powder was buffered to a neutral (~ 7) pH value 
with different buffers. First, HEPES was used (table 9). Subsequently, sodium 
hydrogen carbonate (table 10) was also tested and a Live/Dead staining with both 
buffers was performed (figure 17).  
A B C
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Figure 17: Live/Dead staining of PDLSCs. PDLSCs were put into the following mixtures: A: 0,1 g 
collagen powder + 400 µl medium + 400 µl 2% NaHCO3, B: 2 x 0,1 g collagen powder + 300 µl 
medium + 500 µl  2% NaHCO3, C: 0,1 g collagen powder + 800 µl HEPES.                                                   
 
 
Table 9: Testings with HEPES. 
Collagen powder HEPES pH conclusion 
0.1 g 1 ml 
4.9 – sunk down to 
4.8 after 20 
minutes 
no stable values 
0.1 g 800 µl 
4.3 – sunk down to  
4.2 after 20 
minutes 
no stable values 
 
  
Table 10: Testings with sodium hydrogen carbonate. 
Collagen powder NaHCO3 DMEM-F12 pH 
0.1 g 0.1 g 200 µl 9.1 
0.1 g 0,1 g 500 µl 8.1 
0.1 g 0.1 g 800 µl 8.1 
0.1 g 0.07 g 800 µl 7.9 
0.1 g 0.01 g 800 µl 7.6 
0.2 g 0.01 g 1.6 ml 7.8 
0.1 g 800 µl 2 % NaHCO3 0 µl 7.6 
0.1 g 400 µl 2 % NaHCO3 400 µl 7.1 
0.1 g 600 µl 2 % NaHCO3 200 µl 7.5 
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Finally, a potassium buffer (table 11) was tried. The use of the potassium buffer 
resulted in stable pH values. Therefore, a Live/Dead staining occurred (figure 18) 
and the potassium buffer was used for later implantations (see 2.1.4). Per furcation 
defect 0.05 g collagen powder, 100 µl potassium buffer and 300 µl medium, 
combined with the dental stem cells, were applied. 
 
Table 11: Testings with potassium buffer. 
Collagen powder potassium buffer DMEM-F¹² pH 
0.1 g 300 µl 500 µl 8.0 
0.1 g 200 µl 600 µl 7.5 = optimal 
 
 
 
 
Figure 18: Potassium buffer with PDLSCs. Live/Dead staining of stem cells located in potassium 
buffer and collagen powder, 24 hours after inserting; most cells are alive (colored in green), collagen 
powder presents high self-fluorescence. 
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3.2 Phenotyping of periodontal ligament stem cells  
The dental stem cells used in this study could be successfully isolated and 
characterized. Compared with the isotypes, a positive shift along the x-axis was 
obvious for the surface markers CD 29 and CD 44. For CD 45 a negative antigen 
expression was shown. The following surface markers were proven (figure 19-21): 
 
 
  
Figure 19: Detection of surface molecule CD29. A: deferment of the graphs proves existence of CD 
29. First (grey) graph demonstrates isotype = negative control, second graph (black) demonstrates 
surface marker CD 29, B: iso type of CD 29; C: CD 29 – positive shift visible. 
 
 
 
 
 
 
 
 
 
CD 29:  
A 
B C 
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Figure 20:  Detection of surface molecule CD44. A: deferment of the graphs proves existence of CD 
44. First (grey) graph demonstrates isotype = negative control, second graph (black) demonstrates 
surface marker CD 44, B: iso type of CD 44; C: CD 44 – positive shift visible. 
 
  
CD 44:  A 
B C 
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Figure 21: Detection of surface molecule CD45.  A: no deferment of the graphs shows any 
existence of CD 45. The hemopoietic stem cell marker, first (grey) graph demonstrates isotype =   
negative control, second graph (black) demonstrates surface marker CD 45 B: iso type of CD 45; C: 
CD 45; D: uncoloured sample. 
  
B 
C 
CD 45:  
A 
D 
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3.3 All implanted materials improved regeneration 
 
The aim of this study was to examine the regenerative potential of different collagen 
materials with or without PDLSCs or GF. Therefore, 60 furcation defects were filled 
randomly with the mentioned materials and the healing was compared to control. 
The different filling materials and their newly formed new attachments are presented 
in figure 22. It is apparent that all experimental groups show an increased new 
attachment formation. In contrast to control, all results varied significantly with the 
exception of the collagen matrix plus GF.  
Figure 22: Overview of NA of all implanted materials. Y-axis shows percentages of measured 
tissue in relation to total defect length, x-axis shows different implanted materials and their 
significances in relation to the control group. P was set at p ≤ 0.05 and all data are presented as mean 
± SD, * = significant to control. 
 
The collagen membrane plus GF achieved the highest new attachment level of 
approximately 77.3 ± 20.3 % (figure 23 A). The lowest new attachment level was 
found in the control group (13.0 ± 18.0 %, figure 23 B). In comparison to the control 
group, all tested implanted materials achieved higher new attachment levels. The 
second-highest result was achieved with the collagen matrix (76.9 ± 18.6 %, figure 
23 C), followed by the collagen powder (61.1 ± 31.4 %, figure 23 D), the collagen 
powder plus PDLSCs (65.1 ± 18.9 %, figure 23 E) and the collagen membrane 
(51.7 ± 18.8 %, figure 23 F). All results varied statistically significantly compared to 
the control, with the exception of the collagen matrix plus GF (53.3 ± 34.6 %, figure 
23 G). 
* 
* * * 
* 
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Figure 23: Histological pictures of new attachment formation. A) Collagen membrane plus GF: NA 
is 77.3 ± 20.3 %, B) control group: NA is 13.0 ± 18.0 %, C) collagen matrix: NA is 76.9 ± 18.6 %, D) 
collagen powder: NA is 61.1 ± 31.4 %; E) collagen powder plus PDLSCs: NA is 65.1 ± 18.9 %, F) 
collagen membrane: NA is 51.7 ± 18.8 %; G) collagen matrix plus GF: NA is 53.3 ± 34.6 %. 
 
 
A B
C
G
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Moreover, the epithelial attachment could be decreased when compared to control 
in all experimental groups (figure 24). In comparison to control (epithelial attachment 
formation rate 39.5 ± 28.6 %, figure 25 A) four of the six experimental groups had a 
statistically significant decrease in epithelial attachment formation (collagen 
membrane: 4.7 ± 9.3 %; figure 25 B, collagen membrane plus GF: 0.0 ± 0 %; figure 
25 C, collagen powder: 7.0 ± 15.4 %; figure 25 D, collagen powder plus SC: 
2.2 ± 4.9 %; figure 25 E). In two groups the epithelial attachment was decreased, 
but not statistically significant (collagen matrix: 6.9 ± 15.4 %; figure 25 F, collagen 
matrix plus GF: 20.4 ± 23.2 %; figure 25 G).  
 
 
Figure 24: Overview of EA of all implanted materials. Y-axis shows percentages of measured tissue 
in relation to total defect length, x-axis shows different implanted materials and their significances in 
relation to the control group. P was set at p ≤ 0.05 and all data are presented as mean ± SD, * = 
significant to control. 
 
 
* 
* 
* 
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Figure 25: Histological pictures of epithelial attachment formation. A) Control group: EA is 
39.5 ± 28.6 %, B) collagen membrane: EA is 4.7 ± 9.3 %, C) collagen membrane + GF: EA is 
0.0 ± 0 %, D) collagen powder: EA is 7.0 ± 15.4 %, E) collagen powder + SC: EA is 2.2 ± 4.9 %, F) 
collagen matrix: EA is 6.9 ± 15.4 %, G) collagen matrix + GF: EA is 20.4 ± 23.2 %. 
A B
C D
E F
G
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3.4 The use of additional stem cells improved periodontal regeneration, but 
not significantly 
Considering the carrier materials solely by contrast with the carrier materials plus 
stem cells, it was shown that the stem cells lead to an increased new attachment 
formation. Comparing the collagen powder alone or combined with the periodontal 
ligament stem cells, the new attachment level went from 61.1 ± 31.4 % to 
65.1 ± 18.9 %. This shows, that there is a tendency to improve regeneration, but not 
in a significant way. However, the enhancement of periodontal regeneration using 
periodontal ligament stem cells was not statistically significant in this examination.  
 
3.5 Periodontal regeneration was not improved significantly by the addition 
of growth factors  
There was no significant difference found between the use of the carrier materials 
solely compared to the carrier materials and the additional application of growth 
factors. The effect of the growth factors was controversial, because they showed 
opposing effects. On the one hand, they improved regeneration (collagen 
membrane alone: 51.7 ± 18.8 % versus collagen membrane plus GF: 
77.3 ± 20.3 %). On the other hand, with the additional application of GF the new 
attachment formation decreased (collagen matrix alone: 76.9 ± 18.6 % versus 
collagen matrix plus GF: 53.3 ± 34.6 %). 
 
3.6 There was no significant difference between stem cells and growth  
factors  
Comparing the carrier materials by themselves to the carrier materials plus stem 
cells or growth factors, it could be shown, that the new attachment formation with 
the use of the additional application of PDLSCs or GF did not differ statistically. No 
significant difference in tissue formation was determined. All implanted materials 
improved regeneration, but the additional application of the stem cells or growth 
factors did not lead to a further significant enhancement in new attachment 
formation. Summarized, the addition of GF to the carrier materials resulted in an 
increased variability of the results with high standard deviations. The additional 
application of stem cells improved the outcome insignificantly. Both materials tended 
to improve regeneration, but not in a statistically significant way. 
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4 DISCUSSION 
The aim of this study was to analyze the potential of different collagen carrier 
materials with or without periodontal ligament stem cells or a growth factor cocktail 
in a minipig model, to find new treatment options for periodontal regeneration. 120 
days after surgery the animals were euthanized. With the help of histological 
specimens periodontal regeneration was evaluated to morphologic and 
morphometric aspects. Summarized, all implanted materials showed an increased 
new attachment formation and a reduction of the epithelial attachment. Partially, the 
additional application of periodontal ligament stem cells or growth factors slightly 
improved the healing processes, although this improvement was not statistically 
significant. 
 
4.1 Carrier materials  
In this study, different collagen materials were used as filling materials and carrier 
for the dental stem cells or the growth factor cocktail. The class II furcation defects 
were filled with the above named materials and additionally covered with a 
semipermeable membrane. The semipermeable membrane was used to avoid the 
formation of a long junctional epithelium. Gingival epithelial cells compete with other 
cells for the population of the root surface. Therefore, guided tissue regeneration 
was applied to support periodontal regeneration. With the help of a semipermeable 
membrane epithelial cells were excluded. Thereby, the sufficient supply of oxygen 
inside the tissues was ensured (Rakhmatia et al. 2013).  
Previously, collagen has been proven to be a suitable carrier material in 
regenerative periodontology (Ferreira et al. 2012, Kosen et al. 2012, Zhang et al. 
2006). Therefore, this study investigated if the regenerative potential could be 
further improved by the addition of periodontal ligament stem cells or growth factors. 
Various collagen materials were used in this study: a collagen membrane, a 
collagen matrix and a collagen powder (see 2.1). All implanted materials could 
achieve at least 50 % higher new attachment formation compared to control.  
Collagen is a widely used material in regenerative therapies. It is mostly used as a 
membrane in guided tissue regeneration, but it can also be used as a filling material 
itself. The positive effect and regenerative potential of collagen materials has been 
shown in several studies. It was shown that the formation of functionally oriented 
periodontal ligament, cellular mixed fibre cementum and alveolar bone was 
stimulated in beagle dogs when filling periodontal defects with an absorbable 
collagen sponge in 2013 (Kim et al. 2013). In the same way, Kosen et al. filled class 
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II furcation defects with collagen hydrogel/sponge scaffolds in beagle dogs. After 
two and four weeks of healing the histometric parameters were compared to a 
control and the volume of reconstructed alveolar bone, cementum and new 
periodontal ligament was significantly greater. The new bone volume was 20 % 
greater than in the control group. After 4 weeks of healing, the new cementum level 
was 12 % higher and the new periodontal ligament showed an increase of 13% 
compared to control. The outcomes of the research from Kosen et al. are 
comparable to the results of our study. In our investigation, all treatment groups 
showed an increase of the new attachment formation of at least 28 %. Despite these 
regeneration processes, the collagen also showed a high biocompability and 
degradability (Kosen et al. 2012).  
Another study delivered similar results using a bovine hydroxyapatite/collagen block 
in one-wall intrabony periodontal defects in dogs (Jung et al. 2011). In two out of five 
groups a regeneration of the periodontal tissues could be achieved. Without using a 
barrier membrane, the filling materials did not remain in place and 3 of 5 groups did 
not regenerate periodontal tissues. Again, it was shown, that collagen is a promising 
material for periodontal regeneration in combination with GTR.   
Our study also confirmed that collagen alone, implanted solely, also increased the 
new attachment formation. When compared to control, all collagen materials 
showed a significantly increased periodontal regeneration. There are several studies 
that document that the additional application of dental stem cells or growth factors 
may lead to a further improvement of the periodontal regeneration (Zhang et al. 
2006, Iwata et al. 2009). Zhang et al. used a porous chitosan/collagen scaffold in 
combination with human transforming growth factor-β1 (TGF-β1) in athymic rats. 
Human periodontal ligament cells were seeded into these scaffolds and it was 
shown that the cells did not only proliferate, but also recruited surrounding cells to 
grow in the scaffold. Another study from Sculean et al. tested the effectiveness of a 
composite bovine-derived xenograft and a bioresorbable collagen membrane in 
deep intrabony defects of thirty-two periodontitis patients. The control group with an 
open flap surgery achieved significantly less clinical attachment gain than the 
experimental group (Sculean et al. 2005). Moreover, the epithelial attachment could 
be decreased with all filling materials in this study. So, the implantation of the filling 
materials did not only improve the new attachment formation, it also prevented the 
formation of epithelial attachment. Once more, these results are comparable to the 
results of this research project. In our study, the epithelial attachment was 
decreased with all collagen materials. The results confirm the outcome from Kosen 
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et al. from 2012, where not only were periodontal tissues formed, but also the 
epithelial down-growth was suppressed by the application of collagen hydrogel. 
After four weeks of healing the long junctional epithelium decreased from about 35% 
in the control group to 13% in the experimental group. Also, Jung et al. could evince 
the effectiveness of using a collagen block in beagle dogs. The epithelial attachment 
could be decreased from 0, 93 mm in the control group to 0, 80 mm in the 
experimental group (Jung et al. 2011).  
Taken together, collagen was frequently proven to be a suitable filling material in 
periodontal defects.  
 
4.2 Stem cells  
Stem cells play an increasingly important role in periodontal research. The stem 
cells used in this study were periodontal ligament stem cells. They were isolated 
from the periodontal ligament of extracted teeth. Periodontal ligament stem cells are 
part of the mesenchymal stem cells (Egusa et al. 2012; Horwitz et al. 2005). There 
are different kinds of dental stem cells, for example dental pulp stem cells, stem 
cells from human exfoliated deciduous teeth or dental follicle stem cells (Egusa et al. 
2012). 
The periodontal ligament stem cells were implanted with the collagen powder. 
Thereby, an increase of the new attachment formation and a reduction of the 
epithelial attachment could be achieved. Our outcomes confirm the results of other 
studies. In 2008, Liu et al. showed showed that periodontal regeneration could be 
significantly improved with the use of periodontal ligament stem cells in a porcine 
model (Liu et al. 2008). Those findings were confirmed by the research of Ding et al. 
from 2010. In this study, a significantly better periodontal tissue regeneration 
compared to control could be achieved with allogeneic and autologous periodontal 
ligament stem cells (Ding et al. 2010). Also, a systematic review from Bright et al. 
recapitulated that in 43 studies, using periodontal ligament stem cells in four 
different species of animals (dog, rat, pig and sheep) and various sizes of surgical 
defects, 70,5 % of the results showed an statistically significant improved 
periodontal regeneration (Bright et al. 2015).  
Two studies from Dogan et al. and Akizuki et al. showed that periodontal ligament 
stem cells can prevent epithelial down growth and root resorption. Therefore, 
periodontal ligament stem cells were cultured in vitro and periodontal defects treated 
in vivo. A formation of connective tissue attachment, characterized by parallel 
bundles resting on the root dentin, and a reduction of the epithelial attachment could 
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be observed (Dogan et al. 2002; Akizuki et al. 2005). The efficiency of adipose-
derived stem cells was examined by Tobita et al. in 2008. Their study demonstrated 
that eight weeks after the implantation of adipose-derived stem cells a periodontal-
like structure could be seen in rats (Tobita et al. 2008).  
As with most of the studies mentioned above, our study showed a significant gain of 
new attachment by using PDLSCs when compared to the control. However, there 
was no statistically significant difference when compared to the groups using GF or 
the carrier material alone. The lack of significance may be justified by the small 
number of samples used in this study, resulting in large standard deviations. More 
possible reasons for this phenomenon are discussed in methodological 
considerations (4.4).  
 
4.3 Growth factors 
The growth factors used in this study were implanted with two different collagen 
materials, the collagen matrix and the collagen membrane, and showed 
controversial results. It is supposed that growth factors increase new attachment 
formation and improve periodontal regeneration. Several studies showed that 
growth factors may create an environment which is adjuvant to support a de novo 
tissue formation. They have the ability to regulate various functions of cells 
originating in the periodontal tissues and thereby can improve periodontal 
regeneration (Stavropoulos et al. 2012). In a split-mouth designed study it was also 
shown that growth factors increased the clinical attachment level (Howell et al. 
1997). There were test sites with one of two concentrations of rhPDGF (recombinant 
human platelet-derived growth factor) plus rhIGF-1 (recombinant human insulin-like 
growth factor-1) and a control site containing the carrier only. Clinical attachment 
level gain at test sites was significantly higher than compared to control group.  
Nevins et al. and Jayakumar et al. showed that the clinical attachment level 
improved three months after surgery with the use of growth factors. Also, an 
increased rate of bone growth was observed (Nevins et al. 2013; Jayakumar et al. 
2011). Both resulted in indicating clinical attachment level gain when using platelet-
derived growth factor PDGF-BB (subgroup of the PDGF family) combined with β-
tricalcium phosphate compared to control consisting of β-tricalcium phosphate (β-
TCP) alone.  
A recent study from Kitamura et al. from 2015 investigated if periodontal 
regeneration in intrabony defects could be increased by the use of trafermin, a 
recombinant human fibroblast growth factor. Therefore, a total of 328 periodontitis 
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patients with 4-mm and 3-mm or deeper probing pocket depths and intrabony 
defects were either treated with the fibroblast growth factor or no filling material 
during flap surgery. The study showed that the percentage of bone fill at 36 weeks 
was significantly greater in the growth factor group, but the gain of the clinical 
attachment level was not significantly different between the groups (Kitamura et al. 
2015).  
There is another current systematic review dealing with the clinical efficacy of 
growth factors to enhance tissue repair and tissue regeneration in the oral and 
maxillofacial region from 2015 (Schliephake 2015). This review concludes, that 
autogenous growth factors in platelet concentrates could improve clinical attachment 
level and bone fill significantly, but without any clinical benefit. Therefore, the study 
summarizes that the evidence of clinical efficacy of growth factors in regenerative 
processes in the oral and maxillofacial area is limited. 
Our study confirms the statement from Schliephake. On the one hand, the new 
attachment formation increased when combining the collagen membrane with the 
growth factor cocktail. On the other hand, the new attachment formation decreased 
when the growth factors were combined with the collagen matrix. Thus, the effect of 
the growth factors was controversial in our research. They had different impacts, 
depending on the carrier material used.  
The collagen matrix, made of collagen from the jellyfish Rhopilema spec., may 
contain endotoxins. Kawaguchi et al. described in a research from 1995, that the 
presence of endotoxins induce the production of tumor necrosis factor – alpha (TNF-
alpha). TNF-alpha inhibits the effect of growth factors, for example fibroblast growth 
factor, in the site of the wound. Therefore, the wound healing and the collagen 
production may be decreased by the presence of endotoxins (Kawaguchi et al. 
1995). This might be a possible reason for the lack of significance when using the 
collagen matrix as a filling material in this study. Other studies assert that collagen 
from a jellyfish activates the immune response in vivo (Morishige et al. 2011). 
Growth factors, applied with the correct concentrations, are supposed to improve 
periodontal regeneration. The contentious impact of the growth factors used in this 
study could also be associated with different concentrations. In a study from 
Graziani et al. (Graziani et al. 2006) different concentrations of growth factors and 
their effect on osteoblasts and fibroblasts in the early phase of wound healing were 
examined. In their study, platelet-rich plasma was tested, consisting of seven 
different growth factors. The findings of this study showed that the proliferation of 
these cells is dose dependent, but it is not the highest dose resulting in best 
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proliferation. Another reason for the controversial impacts of the growth factor 
cocktail and also for different growth factor concentrations inside the furcation defect 
may be the different adhesion of the growth factors to the carrier materials. Perhaps, 
the growth factors could attach more easily to the collagen membrane than to the 
collagen matrix. Based on the fact that cell proliferation is a critical event during 
early wound healing, an increased growth factor concentration may not provide the 
optimal environment for wound healing. Therefore, the right concentration that would 
be ideal in periodontal class II furcation defect is yet to be determined. 
 
4.4 Methodological considerations  
In this study we used an animal model to find new treatment options for 
periodontitis. The periodontal ligament stem cells and the growth factor cocktail 
were implanted with different collagen materials in minipigs. The inflammatory 
processes in periodontal diseases in minipigs are similar to the ones in periodontal 
tissues in humans (Štembírek et al. 2012), making the minipigs ideal candidates for 
periodontal research. Minipigs are omnivores and the anatomical structure of their 
teeth and periodontal apparatus resembles humans and the wound healing 
processes are also comparable (Forster et al. 2010). 
The materials were randomly assigned to surgically created class II furcation 
defects. The number of samples was limited. There was a minimum of 4 defects per 
test group due to the regulatory guidelines of animal testings in Germany. Due to the 
small number of samples, the standard deviations are high and an increased 
number of samples would have provided a more meaningful statistic.  
The outcomes and the conclusion of this study are limited by several factors. It is 
difficult to compare the efficacy of the dental stem cells and the growth factors, 
because different carrier materials were used for implantation. The PDLSCs were 
implanted with the collagen powder, whereto the growth factors were implanted 
either with the collagen membrane or the collagen matrix. The use of the different 
carriers makes a direct comparison complex. The material testings prior to 
implantation (2.1.4) showed that the stem cells were not combinable with the 
collagen matrix. Maybe the pH-value of the collagen matrix was not appropriate for 
the survival of the stem cells. Another reason could be the presence of endotoxins 
(4.3). The periodontal ligament stem cells could also not be combined with the 
collagen membrane, wherefore they were only implanted with the collagen powder. 
Pre-trials showed that the stem cells survived at least 24 hours when combined with 
the collagen powder. Maybe further in vitro trials would have been necessary to 
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completely understand the interaction of the collagen powder and the stem cells. 
Furthermore, it is speculated that periodontal ligament cell differentiation is highly 
sensitive to differences in microenvironments. These facts may result in different 
tissue formations, as also seen in this study (Benatti et al. 2007). Considering the 
outcomes of this study, there was an improved periodontal regeneration using the 
PDLSCs. 
The growth factors used in this study were mixed in a growth factor cocktail and may 
differ from growth factor concentrations used in other studies. Therefore, it does not 
provide any insight into the efficacy of the single growth factors used in this cocktail 
(Kaigler et al. 2011). Furthermore, the four different growth factors used in this 
cocktail, may potentially interact among themselves. As mentioned above, it is 
challenging to compare the effectiveness of the growth factor cocktail, because they 
were implanted with different carrier materials to the stem cells. Nevertheless, since 
all implanted collagen materials lead to an increased new attachment formation 
(from 51 % – 79 %), a tendency for the regenerative potential of the additional 
application of growth factors or dental stem cells can be drawn.  
Progenitor cells and dental stem cells play an increasingly important role in 
periodontal research. They have the potential to differentiate into osteoblasts, 
fibroblasts or cementoblasts. Thus, new periodontal tissues can be formed, 
including periodontal ligament, cementum, alveolar bone and ginigiva (Yoshioka et 
al. 2015). Those cells need suitable scaffolds to guarantee a safe application and 
their interaction with the environment (Diomede et al. 2016). Growth factors are also 
supposed to improve periodontal regeneration, but more in vitro studies are 
necessary considering the existing controversies of their efficacy (Vahabi et al. 
2015; Yan et al. 2015).  
In clinical practice, there are several factors influencing periodontal regeneration - 
the health condition of the animal, metabolic processes, genetic factors or different 
immune systems can affect healing processes. Also, the healing process can be 
influenced by the surgeon’s abilities or his clinical experiences. Consequently, the 
regenerative processes in vivo cannot be easily compared with experimental studies 
with stem cells in vitro. 
Environmental factors and individual variations affect wound healing in vivo, but 
have no influence on experimental investigations in vitro.  Therefore, the assumed 
positive impact of stem cells or growth factors in vitro may be overlayed by a 
significant variation of individual factors in vivo. Those individual variations may be 
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presented by the large standard deviations in this study. It can thus be concluded 
that the complexity of a system also increases its variability.  
Also, the results of this research showed that in particular the additional application 
of stem cells and in some cases also the addition of growth factors have a positive, 
but limited effect on regeneration in vivo. Due to the complexity of the clinical 
situation and the variety of factors that influence wound healing the improvement is 
not statistically significant.  
In other fields of medicine similar effects were shown. Corneal transplants in 
combination with adipose tissue derived MSCs did not increase the survival of the 
transplants, but rather increased inflammation in a study with rabbits in 2015 
(Fuentes-Julián et al. 2015). This led to a lower survival of the graft when compared 
to sham-treated corneal transplants. The authors also concluded that there are 
diverse parameters that must be established before MSCs can be useful in corneal 
transplants including cell source, time of injection, immune suppression or number 
of cells. Yeagy et al. used bone marrow stem cells for kidney repair (Yeagy et al. 
2011). In their review they also question the impact of bone marrow stem cells, 
because some authors have shown that bone marrow stem cells can differentiate 
into renal cells and reverse renal dysfunction while others observed inconsistent 
results and doubt their efficacy.  
 
There are several studies investigating the efficacy of stem cells alone in periodontal 
defects in rats. Periodontal fenestration defects were treated with allogeneic 
PDLSCs seeded onto an absorbable gelatin sponge. The results were compared to 
the material alone and a blank. A statistically significant difference was achieved 
within specimens retrieved on day 21 for analysis of regeneration of 
cementum/periodontal ligament (PDL)-like structures (Han et al. 2014). In addition, 
there is a study from Cai et al. from 2015, where mesenchymal stem cells were 
obtained from rats and then pre-cultured under different in vitro conditions. They 
were implanted and it could be shown that a prior in vitro chondrogenic 
differentiation lead to regeneration of alveolar bone and ligament tissues (Cai et al. 
2015). 
Also, there are studies that examine the effectiveness of growth factors alone in 
dogs and in humans. Intrabony 2-wall defects were created bilaterally on the second 
premolar and the first molar in nine dogs. The defects were filled with recombinant 
human platelet-derived growth factor or a ß-tricalcium phosphate matrix. The 
amount of new cementum was significantly higher with the platelet-derived growth 
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factors (Nevins et al. 2012). Another study tested the regenerative potential of GF in 
humans. 83 patients received a local application of β-tricalcium phosphate scaffold 
matrix with or without two different dose levels of recombinant human platelet-
derived growth factor. After 36 months, there was a continuing increase in clinical 
attachment gain; linear bone growth and percentage bone fill over time, suggesting 
overall stability of the regenerative response (Nevins et al. 2013).  
To the best of our knowledge there is no other study comparing the efficacy of 
periodontal ligament stem cells or growth factors in one study while using the same 
animal model. Our study showed that the carrier materials alone or in combination 
with stem cells or growth factors can induce a significantly improved periodontal 
regeneration when compared to the non-treatment control. Both, the addition of the 
dental stem cells or the growth factors to the carrier material did not enhance the 
extent of the periodontal regeneration in a statistically significant way. Also, there 
was no significant difference between stem cells and growth factors (Basan et al. 
2017).  
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5 SUMMARY 
In periodontology, a regeneration of the lost periodontal tissues is still challenging. 
Therefore, the aim of this study was to examine the regenerative potential of 
different collagen materials with and without stem cells or growth factors in a minipig 
animal model.  
In a total of 60 surgically created class II furcation defects the following materials 
were applied: a) different collagen support versus control, b) different collagen 
support +/- a growth factor cocktail and c) a collagen powder versus collagen 
powder + periodontal ligament stem cells. The periodontal ligament stem cells were 
isolated from extracted teeth of 15 adult miniature pigs. The materials were applied 
and a polychrome sequential labeling followed. After 120 days of healing, a 
histological evaluation of the regenerative processes in the furcation defects 
followed.  
In all treatment groups a statistically significant increase in new attachment 
formation was observed. The new attachment reached a maximum of 77 percent of 
the total defect length. On the contrary, in the control group a new attachment 
formation of 13 percent was measured. Equally, the formation of the epithelial 
attachment could be decreased with all materials. The results showed that the 
collagen carrier itself caused significant improvement of regeneration, which was 
already shown in many previous studies. An additional therapeutic effect of stem 
cells or growth factors could be observed, but did not change the outcome 
significantly. One common feature of the application of SC and/or GF was the 
presence of high standard deviations. There were no significant differences between 
all experimental groups. Due to the limitations of this project, it can be assumed that 
the lack of significant differences is caused by the complexity of the clinical setting 
(e.g. operator skills, individual wound healing and differences in defect morphology). 
To sum up, stem cell research seems to be at a point where the basic approaches 
that could be achieved over the last couple of years need to be consolidated for 
promising use in vivo. Our results show that the possible therapeutic effect of stem 
cells or growth factors shown in vitro or in small animal testings cannot always be 
easily transferred into a clinical situation.  
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6 THESIS STATEMENTS 
 
1. All implanted materials improved the formation of the new attachment when 
compared to the controls. 
 
2. The additional application of stem cells did not significantly improve regeneration. 
 
3. The additional application of growth factors did not significantly improve 
regeneration. 
 
4. There was no difference in regeneration process between the growth factors and 
the stem cells. 
 
5. Due to individual factors, the possible effects of stem cells and growth factors in 
vitro may not become evident when applied in vivo.  
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